India, July 31 -- The global organoids market is experiencing explosive growth, valued at $1.74 billion in 2025 and projected to reach $3.49 billion by 2034 at a 15.63 per cent CAGR. While India's organoids and spheroids market specifically generated $153.1 million in 2024 and is expected to reach $603.2 million by 2030, representing a robust 26.6 per cent CAGR.

India's organoid research ecosystem is rapidly developing, with key institutions leading groundbreaking studies across multiple therapeutic areas. The Indian Institute of Science (IISc) in Bengaluru has emerged as a prominent hub, with researchers like Ramray Bhat at the Molecular Reproduction, Development and Genetics (MRDG) department actively studying cancer organoids, particu...